Huntington's disease
ICD-10 G10 · ICD-11 8A01.10

Treatment of Huntington's Disease Presenting with Dystonia

This protocol addresses patients with Huntington's disease who present with dystonia — abnormal postures that may affect all body segments, frequently associated with rigidity. Management in this setting requires specific interventions targeted at the postural and musculoskeletal consequences of dystonia.

The approach for dystonia in Huntington's disease involves both active and passive physiotherapy to preserve joint mobility, as well as targeted interventions for focal dystonia when present — the complete regimen, with full sequencing and criteria, is available in the structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.3389/fneur.2019.00710

Dystonia is characterized by abnormal postures that may affect all body segments and is frequently associated with rigidity.

Both active and passive physiotherapy approaches are recommended as a preventive measure to maintain the range of joint motion, limit postural and musculoskeletal deformities and, prevent the development of contractures.

Injection of botulinum toxin in the case of focal dystonia or to prevent secondary deformities should be performed by a trained professional.

Customized chairs can provide a comfortable environment in view of the dystonia-related deformities.

View source ↗